Aurobindo Pharma USA, Inc. is a generic pharmaceutical manufacturer and distributor and is a wholly owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India. Headquartered in HITEC City, Hyderabad, India, founded in 1986 and becoming a public company in India in 1992.
Aurobindo Pharma USA, Inc. is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Aurobindo Pharma USA, Inc. adds value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes. Aurobindo has business operations in more than 125 countries around the world. Aurobindo is a global pharmaceutical company with a broad portfolio of generic drugs that includes more than 180 product families and 450 individual product packages.
Aurobindo markets over 80% of the top 100 most prescribed products in the world. In past years, Aurobindo has received more ANDA approvals than any of our competitors. Aurobindo is now ranked 2nd among pharmaceutical companies based on Total Prescriptions Dispensed. (We are#27 in 2010)
Capable of performing test methods for complex formulations under general oversight and documenting those experiments per cGMP requirements. Must be able to calculate, organize, and communicate results via standard data templates and reports. Experience in a cGMP laboratory and testing inhaled product (e.g. MDI and DPI) samples is preferred. Must possess good organizational skills, a commitment to quality work, and good oral and written communication skills, and work effectively as part of a team.
Will participate in the development and validation of inhalation test methods through execution of defined experiments under oversight. Test methods to be executed include dose content uniformity, cascade impaction by Next Generation Impactor, Karl Fischer moisture content, spray pattern, plume geometry, etc. Will provide support of inhaled product development programs from reverse engineering through registration stabilities by performing active and excipient assays as well as executing performance test methods on a variety of formulations. Verbal communication of results and observations to the development team as well as written communication via study reports will be necessary.